SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

GUERRINI, Remo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 25.506
EU - Europa 5.825
AS - Asia 4.171
SA - Sud America 46
Continente sconosciuto - Info sul continente non disponibili 12
OC - Oceania 11
AF - Africa 2
Totale 35.573
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 25.413
CN - Cina 2.113
UA - Ucraina 1.617
IT - Italia 1.071
DE - Germania 996
SG - Singapore 966
TR - Turchia 872
GB - Regno Unito 781
FI - Finlandia 406
SE - Svezia 400
PL - Polonia 232
BE - Belgio 95
CA - Canada 93
ID - Indonesia 78
FR - Francia 62
IN - India 29
CZ - Repubblica Ceca 25
VN - Vietnam 24
IR - Iran 23
LT - Lituania 21
RU - Federazione Russa 20
BR - Brasile 19
NL - Olanda 18
AT - Austria 17
JP - Giappone 17
NO - Norvegia 16
KR - Corea 12
CO - Colombia 11
HK - Hong Kong 11
RO - Romania 10
CL - Cile 8
EU - Europa 8
AU - Australia 6
CH - Svizzera 6
IE - Irlanda 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AR - Argentina 4
PE - Perù 4
TW - Taiwan 4
DK - Danimarca 3
ES - Italia 3
GR - Grecia 3
HR - Croazia 3
PH - Filippine 3
PK - Pakistan 3
AE - Emirati Arabi Uniti 2
BD - Bangladesh 2
BG - Bulgaria 2
DZ - Algeria 2
IL - Israele 2
IQ - Iraq 2
LB - Libano 2
LU - Lussemburgo 2
PT - Portogallo 2
AL - Albania 1
IS - Islanda 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LI - Liechtenstein 1
MC - Monaco 1
MM - Myanmar 1
NP - Nepal 1
TH - Thailandia 1
Totale 35.573
Salva come PNG Salva come JPEG
Città #
Fairfield 3.528
Woodbridge 3.260
Houston 2.097
Jacksonville 1.838
Ashburn 1.693
Ann Arbor 1.682
Chandler 1.534
Seattle 1.397
Wilmington 1.256
Cambridge 1.191
Singapore 743
Santa Clara 737
Izmir 544
Nanjing 492
Princeton 405
Beijing 392
Ferrara 388
Boardman 304
San Diego 304
Milan 220
Warsaw 212
New York 179
Shanghai 171
Shenyang 154
Nanchang 151
Dearborn 146
Los Angeles 134
Falls Church 125
San Mateo 113
Jiaxing 96
Brussels 90
Tianjin 87
Addison 84
Hebei 84
Changsha 81
Mountain View 81
Munich 80
Jakarta 78
Redwood City 77
Bremen 74
Norwalk 72
Helsinki 71
Jinan 61
London 61
Washington 57
Auburn Hills 51
Zhengzhou 51
Philadelphia 47
Kunming 45
Montréal 35
Ningbo 35
Tappahannock 34
Toronto 34
Guangzhou 33
Des Moines 29
Bologna 28
Mcallen 27
Indiana 25
Verona 24
Ferrara di Monte Baldo 22
Orange 21
Dong Ket 20
Redmond 18
Frankfurt am Main 17
Lanzhou 17
Ottawa 17
Taizhou 17
Leawood 16
Oslo 16
Brno 15
St Louis 14
Augusta 13
Parma 13
Vienna 13
San Francisco 12
Changchun 11
Hefei 11
Padova 11
Ardabil 10
Prescot 10
Fuzhou 9
Hangzhou 9
Kilburn 9
Wroclaw 9
Bari 8
Florence 8
Hong Kong 8
Hounslow 8
Walnut 8
Chiswick 7
Haikou 7
Medellín 7
Olomouc 7
Springfield 7
Turin 7
Chicago 6
Osasco 6
Waltham 6
Yellow Springs 6
Chisinau 5
Totale 27.583
Salva come PNG Salva come JPEG
Nome #
AGONISTI PIENI E PARZIALI ED ANTAGONISTI DEL RECETTORE PER NOCICETTINA/ORFANINA FQ AD ELEVATA POTENZA” 209
Design and synthesis of99mTcN-labeled dextran-mannose derivatives for sentinel lymph node detection 184
Involvement of cell surface TG2 in the aggregation of K562 cells triggered by gluten 178
A diastereoselective synthesis of Cebranopadol, a novel analgesic showing NOP/mu mixed agonism 175
Design, synthesis and biological characterization of novel mitochondria targeted dichloroacetate-loaded compounds with antileukemic activity 171
A novel and facile synthesis of tetra branched derivatives of nociceptin/orphanin FQ 169
[(pF)Phe4,Arg14,Lys15]N/OFQ-NH2 (UFP-102), a highly potent and selective agonist of the nociceptin/orphanin FQ receptor 166
Neuropeptide S reduces mouse aggressiveness in the resident/intruder test through selective activation of the neuropeptide S receptor 153
Structure-activity studies on the nociceptin/orphanin FQ receptor antagonist 1-benzyl-N-{3-[spiroisobenzofuran-1(3H),4'-piperidin-1-yl]propyl} pyrrolidine-2-carboxamide. 151
Physicochemical stability of cabazitaxel and docetaxel solutions 149
AGHLDDLPGALSAL: A hemoglobin fragment potentially competing with albumin to bind transition metal ions 147
A new selective antagonist of the nociceptin receptor 146
N- and C-terminal modifications of nociceptin/orphanin FQ generate highly potent NOP receptor ligands 145
[Dmt(1) ]N/OFQ(1-13)-NH(2) , a potent nociceptin/orphanin FQ and opioid receptor universal agonist. 145
[Nphe(1),Arg(14),Lys(15)]nociceptin-NH2, a novel potent and selective antagonist of the nociceptin/orphanin FQ receptor 144
Behavioural phenotypic characterization of CD-1 mice lacking the neuropeptide S receptor 143
Anxiolytic- and panicolytic-like effects of Neuropeptide S in the mouse elevated T-maze. 142
Structure activity studies of nociceptin/orphanin FQ(1–13)-NH2 derivatives modified in position 5 142
Tryptophan replacement in the nociceptin/orphanin FQ receptor ligand Ac-RYYRWK-NH2 141
Conformation-activity relationship of neuropeptide S and some structural mutants: Helicity affects their interaction with the receptor 140
Cell and tissue responses of a range of Urotensin II analogs at cloned and native urotensin II receptors. Evidence for coupling promiscuity 138
Pharmacological profile of nociceptin/orphanin FQ receptors interacting with G-proteins and β-arrestins 2 138
Beta-arrestin 2 rather than G protein efficacy determines the anxiolytic- versus antidepressant-like effects of nociceptin/orphanin FQ receptor ligands 138
Acid catalysis in the formation of dioxopiperazines from peptides containing tetrahydroisoquinoline‐3‐carboxylic acid at position 2 137
Intrathecal administration of nociceptin/orphanin FQ receptor agonists in rats: A strategy to relieve chemotherapy-induced neuropathic hypersensitivity 136
Pharmacological characterization of nociceptin receptor: an in vitro study 136
Nociceptin/orphanin FQ induces simultaneously anxiolytic and amnesic effects in the mouse elevated T-maze task. 134
A new ligand for the urotensin II receptor 134
[D-Pen(p-tBuBzl)5]NPS, a novel ligand for the neuropeptide S receptor: structure activity and pharmacological studies 134
Characterisation of the novel mixed Mu-NOP peptide ligand dermorphin-N/OFQ (DeNo) 134
In vitro and in vivo studies on UFP-112, a novel potent and long lasting agonist selective for the nociceptin/orphanin FQ receptor 133
Identification of an achiral analogue of J-113397 as potent nociceptin/orphanin FQ receptor antagonist 132
UFP-112 a Potent and Long-Lasting Agonist Selective for the Nociceptin/Orphanin FQ Receptor 132
Preferential interaction of the Alzheimer peptide Aβ-(1-42) with Omega-3-containing lipid bilayers: Structure and interaction studies 132
In vitro pharmacological characterisation of a novel cyclic nociceptin/orphanin FQ analogue c[Cys(7,10)]N/OFQ(1-13)NH2 130
Cationic liposomes as potential carriers for ocular administration of peptides with anti-herpetic activity 130
Pharmacological studies on the NOP and opioid receptor agonist PWT2-[Dmt(1)]N/OFQ(1-13) 130
Structure-and conformation-Activity studies of nociceptin/orphanin FQ receptor dimeric ligands 130
Blockade of nociceptin/orphanin FQ-NOP receptor signalling produces antidepressant-like effects: pharmacological and genetic evidences from the mouse forced swimming test 130
Synthesis and biological activity of human neuropeptide S analogues modified in position 2 129
Studies of the cardiovascular effects of nociceptin and related peptides 128
Pharmacology of [Tyr(1)]nociceptin analogs: receptor binding and bioassay studies 128
Blockade of nociceptin/orphanin FQ receptor signaling in rat substantia nigra pars reticulata stimulates nigrostriatal dopaminergic transmission and motor behavior 127
UFP-101 antagonizes the spinal antinociceptive effects of nociceptin/orphanin FQ; Behavioral and electrophysiological studies in mice 125
Cardiovascular effects of nociceptin in unanesthetized mice 124
Antidepressant activity of nociceptin/orphanin FQ receptor antagonists in the mouse learned helplessness 124
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 124
Disordered Peptides Looking for Their Native Environment: Structural Basis of CB1 Endocannabinoid Receptor Binding to Pepcans 124
[(t)Bu-d-Gly(5)]NPS, a pure and potent antagonist of the neuropeptide S receptor: In vitro and in vivo studies 123
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 123
Zn(II) and Ni(II) complexes with poly-histidyl peptides derived from a snake venom 123
The Importance of Ligand-Receptor Conformational Pairs in Stabilization: Spotlight on the N/OFQ G Protein-Coupled Receptor 123
Copper complexes of glycyl-histidyl-lysine and two of its synthetic analogues: chemical behaviour and biological activity 123
Endogenous nociceptin/orphanin FQ signalling produces opposite spinal antinociceptive and supraspinal pronociceptive effects in the mouse formalin test: Pharmacological and genetic evidences 122
Further studies on nociceptin-related peptides: Discovery of a new chemical template with antagonist activity on the nociceptin receptor 122
Anti-inflammatory and analgesic effects displayed by peptides derived from PKI55 protein, an endogenous protein kinase C inhibitor 122
null 121
[Nphe(1)]nociceptin-(1-13)-NH2 antagonizes nociceptin effects in the mouse colon 121
Structure-activity study of the nociceptin(1-13)-NH2 N-terminal tetrapeptide and discovery of a nociceptin receptor antagonist 121
Address and message sequences for the nociceptin receptor: A structure-activity study of nociceptin-(1-13)-peptide amide 121
In vitro pharmacological characterization of a novel unbiased NOP receptor-selective nonpeptide agonist AT-403 120
Structure-activity relationship study of position 4 in the urotensin-II receptor ligand U-II(4-11) 119
Mixed tridentate π-donor and monodentate π -acceptor ligands as chelating systems for rhenium-188 and technetium-99m nitrido radiopharmaceuticals 119
Pharmacological characterization of the nociceptin/orphanin FQ receptor non peptide antagonist Compound 24. 119
Selective breeding for high anxiety introduces a synonymous SNP that increases neuropeptide s receptor activity 119
Pharmacological characterization of the nociceptin receptor mediating hyperphagia: identification of a selective antagonist 118
Calmodulin Binding Sites of the Skeletal, Cardiac, and Brain Ryanodine Receptor Ca2+ Channels: Modulation by the Catalytic Subunit of cAMP-Dependent Protein Kinase? 118
Effects of neuropeptide S on seizures and oxidative damage induced by pentylenetetrazole in mice. 118
Synthesis and Biological Activity of Human Neuropeptide S Analogues Modified in Position 5: Identification of Potent and Pure Neuropeptide S Receptor Antagonists. 118
[Nphe(1)]N/OFQ-(1-13)-NH2 is a competitive and selective antagonist at nociceptin/orphanin FQ receptors mediating K+ channel activation in rat periaqueductal gray slices 117
Effects of chronic nociceptin/orphanin FQ exposure on cAMP accumulation and receptor density in Chinese, hamster ovary cells expressing human nociceptin/orphanin FQ receptors 117
Pharmacological characterization of tachykinin tetrabranched derivatives 117
[Nphe(1)]nociceptin-(1-13)NH2 selectively antagonizes nociceptin effects in the rabbit isolated ileum 116
Characterization of nociceptin receptors in the periphery: in vitro and in vivo studies 116
Structure-activity study at positions 3 and 4 of human neuropeptide S. 116
Role of nociceptin/orphanin FQ receptors in the decrease of mucosal mast cells caused by acute stress in the rat colon. 115
Activation of epitope-specific memory cytotoxic T lymphocyte responses by synthetic peptides 115
Copper-ion interaction with the 106-113 domain of the prion protein: a solution-equilibria study on model peptides 114
Pharmacological characterization of the nociceptin receptor mediating hyperalgesia in the mouse tail withdrawal assay 114
Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist 114
Crystal structures of dipeptides containing the Dmt-Tic pharmacophore 114
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 114
Design of d-opioid peptide antagonists for emerging drug applications 114
Assessment of the activity of a novel nociceptin/orphanin FQ analogue at recombinant human nociceptin/orphanin FQ receptors expressed in Chinese hamster ovary cells 113
Copper Binding to the Neurotoxic Peptide PrP106-126. Thermodynamic and Structural Studies 113
Synthesis and antimicrobial activity of dermaseptin S1 analogues 113
In vitro and in vivo pharmacological characterization of the novel neuropeptide S receptor ligands QA1 and PI1 113
Study of synthetic peptides derived from the PKI55 protein, a protein kinase C modulator, in human neutrophils stimulated by the methyl ester derivative of the hydrophobic N-formyl tripeptide for-Met-Leu-Phe-OH. 112
Structure-activity relationship study on Tyr9 of urotensin-II(4-11): identification of a partial agonist of the UT receptor. 112
Protein–protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase 112
The SH3 domain of nebulin binds selectively to type II peptides: theoretical prediction and experimental validation 112
[Arg(14), Lys(15)]nociceptin, a highly potent agonist of the nociceptin/orphanin FQ receptor: in vitro and in vivo studies 112
Pharmacological profile of hemokinin 1: a novel member of the tachykinin family 111
Opioid diketopiperazines: Synthesis and activity of a prototypic class of opioid antagonists 110
Opioid receptor selectivity alteration by single residue replacement: Synthesis and activity profile of [Dmt]deltorphin B 110
Nociceptin/orphanin FQ inhibits ischaemia-induced glutamate efflux from rat cerebrocortical slices 110
Further studies on the pharmacological features of the nociceptin/orphanin FQ receptor ligand ZP120 110
Studies on the antinociceptive effect of [Nphe(1)]nociceptin(1-13)NH2 in mice 110
Desensitisation of native and recombinant human urotensin-II receptors. 110
null 110
Totale 12.850
Salva come PNG Salva come JPEG
Categoria #
all - tutte 167.764
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.961
Totale 169.725
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.259 0 0 0 0 608 991 819 878 690 730 350 193
2020/20215.193 418 485 243 646 226 558 184 616 162 700 649 306
2021/20224.133 164 406 403 268 268 173 239 266 143 316 321 1.166
2022/20233.870 418 165 124 474 638 536 195 380 544 21 225 150
2023/20241.918 225 248 114 49 110 296 74 176 41 39 62 484
2024/20252.378 214 186 727 258 993 0 0 0 0 0 0 0
Totale 36.087